BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 25658832)

  • 1. Somatic copy number alterations associated with Japanese or endometriosis in ovarian clear cell adenocarcinoma.
    Okamoto A; Sehouli J; Yanaihara N; Hirata Y; Braicu I; Kim BG; Takakura S; Saito M; Yanagida S; Takenaka M; Yamaguchi N; Morikawa A; Tanabe H; Yamada K; Yoshihara K; Enomoto T; Itamochi H; Kigawa J; Matsumura N; Konishi I; Aida S; Aoki Y; Ishii N; Ochiai K; Akiyama T; Urashima M
    PLoS One; 2015; 10(2):e0116977. PubMed ID: 25658832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomics to immunotherapy of ovarian clear cell carcinoma: Unique opportunities for management.
    Oda K; Hamanishi J; Matsuo K; Hasegawa K
    Gynecol Oncol; 2018 Nov; 151(2):381-389. PubMed ID: 30217369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying the biological basis of GWAS hits for endometriosis.
    Fung JN; Rogers PA; Montgomery GW
    Biol Reprod; 2015 Apr; 92(4):87. PubMed ID: 25695719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden.
    Anglesio MS; Bashashati A; Wang YK; Senz J; Ha G; Yang W; Aniba MR; Prentice LM; Farahani H; Li Chang H; Karnezis AN; Marra MA; Yong PJ; Hirst M; Gilks B; Shah SP; Huntsman DG
    J Pathol; 2015 Jun; 236(2):201-9. PubMed ID: 25692284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional evaluation of genetic variants associated with endometriosis near GREB1.
    Fung JN; Holdsworth-Carson SJ; Sapkota Y; Zhao ZZ; Jones L; Girling JE; Paiva P; Healey M; Nyholt DR; Rogers PA; Montgomery GW
    Hum Reprod; 2015 May; 30(5):1263-75. PubMed ID: 25788566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating microRNAs as potential biomarkers for endometriosis.
    Cho S; Mutlu L; Grechukhina O; Taylor HS
    Fertil Steril; 2015 May; 103(5):1252-60.e1. PubMed ID: 25772772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of susceptibility genes for peritoneal, ovarian, and deep infiltrating endometriosis using a pooled sample-based genome-wide association study.
    Borghese B; Tost J; de Surville M; Busato F; Letourneur F; Mondon F; Vaiman D; Chapron C
    Biomed Res Int; 2015; 2015():461024. PubMed ID: 25722978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replication and meta-analysis of previous genome-wide association studies confirm vezatin as the locus with the strongest evidence for association with endometriosis.
    Pagliardini L; Gentilini D; Sanchez AM; Candiani M; Viganò P; Di Blasio AM
    Hum Reprod; 2015 Apr; 30(4):987-93. PubMed ID: 25678572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sunitinib in endometriosis: from bench to bedside.
    Ferrero S; Leone Roberti Maggiore U
    J Obstet Gynaecol; 2015; 35(7):769. PubMed ID: 25671435
    [No Abstract]   [Full Text] [Related]  

  • 10. Genomic landscapes of ovarian clear cell carcinoma from latin countries reveal aberrations linked to survival and progression.
    Batista MP; Roffé M; Romero I; López-Guerrero JA; Illueca C; Lopez R; Balieiro Anastácio da Costa AA; De Brot L; Molina JP; Barboza L; Peria FM; Chaud F; Gouvêa Yamada AS; Poveda A; Rego EM
    BMC Cancer; 2023 Jul; 23(1):613. PubMed ID: 37400764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review the progression of ovarian clear cell carcinoma from the perspective of genomics and epigenomics.
    Tong A; Di X; Zhao X; Liang X
    Front Genet; 2023; 14():952379. PubMed ID: 36873929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Potential microRNA Panels for Male Non-Small Cell Lung Cancer Identification Using Microarray Datasets and Bioinformatics Methods.
    Haranguș A; Lajos R; Budisan L; Zanoaga O; Ciocan C; Bica C; Pirlog R; Simon I; Simon M; Braicu C; Berindan-Neagoe I
    J Pers Med; 2022 Dec; 12(12):. PubMed ID: 36556276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9 Screening for Identification of Genes Required for the Growth of Ovarian Clear Cell Carcinoma Cells.
    Kawabata A; Hayashi T; Akasu-Nagayoshi Y; Yamada A; Shimizu N; Yokota N; Nakato R; Shirahige K; Okamoto A; Akiyama T
    Curr Issues Mol Biol; 2022 Apr; 44(4):1587-1596. PubMed ID: 35723366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PHOSPHATE exporter XPR1/SLC53A1 is required for the tumorigenicity of epithelial ovarian cancer.
    Akasu-Nagayoshi Y; Hayashi T; Kawabata A; Shimizu N; Yamada A; Yokota N; Nakato R; Shirahige K; Okamoto A; Akiyama T
    Cancer Sci; 2022 Jun; 113(6):2034-2043. PubMed ID: 35377528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SALL Proteins; Common and Antagonistic Roles in Cancer.
    Álvarez C; Quiroz A; Benítez-Riquelme D; Riffo E; Castro AF; Pincheira R
    Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of miR-155 in Nutrition: Modulating Cancer-Associated Inflammation.
    Zanoaga O; Braicu C; Chiroi P; Andreea N; Hajjar NA; Mărgărit S; Korban SS; Berindan-Neagoe I
    Nutrients; 2021 Jun; 13(7):. PubMed ID: 34210046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired Evolution of Mitochondrial Metabolism Regulated by HNF1B in Ovarian Clear Cell Carcinoma.
    Yamaguchi K; Kitamura S; Furutake Y; Murakami R; Yamanoi K; Taki M; Ukita M; Hamanishi J; Mandai M
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34067626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How Does Endometriosis Lead to Ovarian Cancer? The Molecular Mechanism of Endometriosis-Associated Ovarian Cancer Development.
    Yachida N; Yoshihara K; Yamaguchi M; Suda K; Tamura R; Enomoto T
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33809880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updates of Pathogenesis, Diagnostic and Therapeutic Perspectives for Ovarian Clear Cell Carcinoma.
    Zhu C; Xu Z; Zhang T; Qian L; Xiao W; Wei H; Jin T; Zhou Y
    J Cancer; 2021; 12(8):2295-2316. PubMed ID: 33758607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precision medicine for ovarian clear cell carcinoma based on gene alterations.
    Kuroda T; Kohno T
    Int J Clin Oncol; 2020 Mar; 25(3):419-424. PubMed ID: 32020380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.